LMTK2 and prostate carcinoma: The LMTK2 expression had no significant ethnic heterogeneity, as demonstrated in multi-ethnic prostate cancer populations from California with African and Latino background, or from Hawaii from native, Japanese or European descent (Waters et al., 2009).